Core Laboratories (CLB) Reports In-Line Q4 EPS

Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the quarter came in at $149.5 million versus the consensus estimate of $145.78 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• ServiceNow to report Q2 2026 results on July 22
• Grindr upgraded on premium tier and telehealth growth potential